RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Rituxan
Related studies linked through entity extraction aliases.
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
- Status
- RECRUITING
- Phase
- PHASE1
T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stem Cell Transplantation for Stiff Person Syndrome (SPS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
- Status
- COMPLETED
- Phase
- PHASE3
PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
- Status
- COMPLETED
- Phase
- NA
Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)
- Status
- COMPLETED
- Phase
- PHASE2
GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
- Status
- COMPLETED
- Phase
- NA
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan
- Status
- COMPLETED
- Phase
- PHASE2